OncoCyte earnings preview: what Wall Street is expecting

  • OncoCyte is reporting earnings from Q4 on March 29.
  • Analysts expect losses per share of $0.094.
  • Go here to watch OncoCyte stock price in real-time on Markets Insider.

On March 29, OncoCyte is reporting latest earnings.

Forecasts of 5 analysts expect losses of $0.094 per share compared to losses of $0.390 per share from the same quarter last year.

Wall Street expects sales to decrease by 60.45% over the previous year’s quarter to $3.6 million.

Analysts expect a loss of $0.359 per share this year. A year earlier, the company lost $0.720 per share.

This story was written by Markets Insider’s RoboEddy, which automatically writes these stories based on data provided by our partners.

Source link

What do you think?

Written by Linkedin

Viral Pope AI Image Shows The Power Of AI

Latest “Webcams Market” Companies & Forecast by 2031